Skip to content

Healing of chronic non-healing wounds with Nanofat grafting.

Impact of Nanofat grafting on healing outcomes in chronic non-healing wounds: A randomized, controlled study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080589
Enrollment
40
Registered
2025-02-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: nanofat grafting in people with chronic or acute wounds: The patients fat tissue is first removed from a donor site, such as the back, abdomen, or hips, in order to create nanofat. A ty

Sponsors

DY Patil Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: subject with acute/chronic wound or ulcers wounds with adequate arterial blood supply in the target limb adequately debrided wound without any slough

Exclusion criteria

Exclusion criteria: severe debility Patients on ventilator support Are pregnant or lactating Have a known allergy or are sensitive to any dressing material Have a known or suspected disease of the immune system Have has had surgery in past 30days to increase blood flow into your leg or foot Patients who refused to give consent

Design outcomes

Primary

MeasureTime frame
1. Faster healing of chronic and acute wounds and ulcer in nanofat graft vs standard care 2. Reduce size of wound in nanofat graft vs standard careTimepoint: check dressing will be done on Post Operative Day 3. Followed by 6th day and 9th then in 2nd week, 3rd week and 4th week.

Secondary

MeasureTime frame
Safety in nanofat graft vs standard careTimepoint: 2 weeks

Countries

India

Contacts

Public ContactDr Vinitha Nair

Padmashree Dr. DY Patil School of medicine

manpreet.juneja@dypatil.edu9823457277

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026